News
While many believe the agents to be potential game changers, evidence is still lacking in psoriatic disease, and experts urge ...
Low rates of retained gastric contents were seen in endoscopy patients on GLP-1 receptor agonists ( RAs), a retrospective ...
Table of Contents The Real Story Behind Your Changing Body Making Every Bite Count When You’re Eating Less Your Brain […] The ...
GLP-1 anti-obesity medications are linked with improvements in testosterone levels and health outcomes for men with obesity ...
After interviewing dozens of people on weight loss drugs like Zepbound and Ozempic, my view of GLP-1s has completely changed ...
After the American Academy of Pediatrics recommended the use of certain GLP-1 weight loss drugs in January of 2023, the use ...
Discover how food brands can adapt to the rising GLP-1 trend. As weight-loss drugs reshape consumer habits, learn which ...
Weight-loss drugs like semaglutide and tirzepatide may help shrink waistlines, but new research shows they fail to boost ...
More than one-third of people who helped develop the 2023 guidelines for treating children with obesity had undisclosed ...
22h
HealthDay on MSNDementia Risk Does Not Differ With GLP-1 RAs, DPP4is for Seniors With T2DMFor older adults with diabetes, there is no clear evidence to suggest that the incidence of dementia differs for those using ...
For older adults with diabetes, there is no clear evidence to suggest that the incidence of dementia differs for those using ...
For patients with idiopathic intracranial hypertension (IIH), glucagon-like peptide 1 receptor agonist (GLP-1 RA) treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results